Abstract: Disclosed herein are deuterium-enriched N-Aryl pyridinone compounds, optionally in combination with one or more additional therapeutic agents, pharmaceutical compositions comprising the same, methods of preparation thereof, and methods of use thereof. Such compounds and compositions are useful, for example, in treating diseases, disorders, or conditions such as edema.
Type:
Application
Filed:
January 7, 2021
Publication date:
July 8, 2021
Applicant:
PureTech LYT 100, Inc.
Inventors:
Eric Elenko, Michael C. Chen, LuAnn Sabounjian